September 29, 2025 · Form 4 insider transaction
Warren Lucinda bought 125,000 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 57 days after the transaction.
This stock option becomes fully exercisable on the first anniversary of the grant date.